Taiwan has ramped up production and imports of the main drug used to treat mycoplasma pneumoniae in children, amid a surge in cases of the respiratory illness reported in China in recent weeks, the Taiwan Food and Drug Administration (TFDA) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
New Zealand opens e-Gate service to Taiwanese passport holders
10/13/2025 02:12 PM - Society
EVA Air investigating death of flight attendant who fell ill on duty
10/13/2025 02:08 PM - Business
Taiwan shares close down 1.39%
10/13/2025 01:52 PM - Politics
On-time delivery of prototype sub 'extremely challenging': Defense chief
10/13/2025 01:40 PM - Culture
Hawaiian International Film Festival to showcase 7 Taiwanese productions
10/13/2025 12:55 PM